patient-related
|
age
|
126 |
0.973 (0.942–1.006); p = 0.103
|
1.008 (0.983–1.033); p = 0.553 |
gender
|
|
|
p = 0.624 |
p = 0.061
|
female |
47 |
1.255 (0.507–3.106) |
2.202 (0.965–5.024)
|
male |
79 |
1 (ref) |
1 (ref)
|
birth region
|
|
|
p = 0.589 |
p = 0.005
|
Africa |
23 |
0.679 (0.216–2.137); p = 0.508 |
0.000 (0.000-.); p = 0.998
|
The Americas |
12 |
0.385 (0.073–2.022); p = 0.259 |
0.886 (0.158–4.974); p = 0.890
|
Eastern Mediterranean |
23 |
0.288 (0.072–1.154); p = 0.079 |
0.664 (0.154–2.874); p = 0.584
|
Europe |
38 |
1 (ref) |
1 (ref)
|
South East Asia |
17 |
0.000 (0.000-.); p = 0.998 |
3.100 (0.873–11.007); p = 0.080
|
Western Pacific |
13 |
0.000 (0.000-.); p = 0.999 |
53.143 (5.896–478.992); p<0.001
|
ethnicity
|
|
|
p = 0.002
|
p = 0.391 |
native dutch |
28 |
4.583 (1.738–12.088)
|
0.626 (0.215–1.823) |
foreign-born |
97 |
1 (ref)
|
1 (ref) |
house setting
|
|
|
p = 0.787 |
p = 0.033
|
rural |
81 |
1 (ref) |
1 (ref)
|
urban |
45 |
0.878 (0.343–2.248) |
0.345 (0.129–0.918)
|
BCG vaccination
|
|
|
p = 0.668 |
p = 0.751 |
no |
27 |
1.306 (0.385–4.431) |
0.842 (0.291–2.433) |
yes |
39 |
1 (ref) |
1 (ref) |
co-morbidities
|
|
|
p = 0.371 |
p = 0.414 |
no or unknown |
109 |
1 (ref) |
1 (ref) |
yes |
18 |
0.494 (0.106–2.312) |
0.579 (0.156–2.148) |
alcohol or drug use
|
|
|
p = 0.949 |
p = 0.243 |
no or unknown |
116 |
1 (ref) |
1 (ref) |
yes |
11 |
0.949 (0.192–4.707) |
0.287 (0.035–2.334) |
homelessness
|
|
|
p = 0.753 |
p = 0.978 |
no or unknown |
123 |
1 (ref) |
1 (ref) |
yes |
4 |
1.499 (0.144–14.573) |
1.033 (0.104–10.310) |
microorganism-related
|
lineage
|
|
|
p = 0.220 |
- |
EAI |
18 |
0.107 (0.013–0.860); p = 0.036 |
- |
EAm |
65 |
1 (ref) |
- |
EAs |
10 |
0.000 (0.000-.); p = 0.999 |
- |
IO |
31 |
0.000 (0.000-.); p = 0.998 |
1 |
antibiotic resistance
|
|
|
p = 0.659 |
p = 0.979 |
none or unknown |
118 |
1 (ref) |
1 (ref) |
resistant |
8 |
1.455 (0.275–7.696) |
1.023 (0.196–5.349) |
transmissibility
|
|
|
p = 0.003
|
p = 0.097
|
no |
49 |
4.242 (1.650–10.907)
|
0.467 (0.190–1.148)
|
yes |
78 |
1 (ref)
|
1 (ref)
|
disease-related
|
disease localization
|
|
|
p = 0.573 |
p = 0.002
|
pulmonary TB |
82 |
1 (ref) |
1 (ref)
|
extra-pulmonary TB |
24 |
0.589 (0.156–2.222); p = 0.435 |
5.279 (1.983–14.049); p = 0.001
|
pulmonary and extra-pulmonary TB |
20 |
1.375 (0.435–4.343); p = 0.587 |
0.788 (0.205–3.038); p = 0.730
|